Analysts Predict Strong Upside for JHMM and Underlying Holdings

Strong upside potential is highlighted for John Hancock Multifactor Mid Cap ETF and its holdings. Analysts have a $70.42 target for JHMM, suggesting a 23.56% increase from current levels.

Date: 17-03-2025

AI Rating: 7

Overview of Analyst Expectations

The report provides insights into the performance and future expectations for the John Hancock Multifactor Mid Cap ETF (JHMM) and its underlying holdings. With a current trading price of $56.99, JHMM has a significant implied upside of 23.56% based on the average analyst target price of $70.42.

Key Holdings Analysis

Among the ETF's underlying holdings, three stocks stand out for their impressive upside potential:

Viking Therapeutics Inc (VKTX): Current price is $30.89, with an average analyst target of $99.73, indicating an upside of 222.87%.
PACS Group Inc (PACS): Recent share price is $11.81, with a target price of $32.67, suggesting a 176.60% increase.
Civitas Resources Inc (CIVI): Trading at $33.62, expected to rise to $65.67, representing a 95.32% upside.

These projected increases reflect strong optimism among analysts regarding the future performance of these stocks.

Potential Risks and Considerations

While the reported upside is significant, the analysis questions whether analysts are justified in their targets or being overly optimistic. A high target relative to current trading prices might suggest potential downgrades if economic conditions change or if the companies fail to meet expectations. Investors should conduct further research to mitigate risks associated with such optimistic projections.

Stocks: JHMM VKTX PACS CIVI